抑制膜攻击复合物可减轻脑室内出血后脑室扩大与铁过载
该研究在大鼠脑室内出血(IVH)模型中观察膜攻击复合物(MAC)激活时程及MAC抑制剂金精三羧酸(ATA)的作用。MAC在出血后1天出现于血肿内并持续至第7天;ATA组在出血后1天和3天脑室体积显著小于溶媒组、血肿内溶血更少,28天时脑室扩大和室周铁沉积显著减轻,功能测试表现更优。
要点
- 大鼠IVH后MAC在血肿内早期激活并持续至第7天。
- ATA组出血后1天和3天脑室体积显著小于溶媒组,血肿内溶血更少。
- ATA组28天脑室扩大和室周铁沉积显著减轻,功能表现优于溶媒组。
核心结论
- MAC在IVH后早期激活并持续存在于血肿内至第7天。
- MAC抑制在IVH急性期减轻血凝块内溶血和脑室扩大。
- 出血后1个月,MAC抑制减轻脑室扩大和铁蓄积并改善功能结局。
研究设计与样本
- 研究分四部分,均使用年轻成年雄性大鼠行立体定向脑室内注射。
- 第一部分24只大鼠注射自体血或生理盐水,出血后第1、3或7天行MRI。
- 第二部分18只大鼠注射生理盐水、含ATA溶媒的自体血或溶媒自体血,出血后第1天和第3天行系列MRI。
- 第三部分12只大鼠行上述脑室内注射,出血后2小时行MRI。
- 第四部分24只大鼠行上述脑室内注射,出血后第1、7、14和28天行系列MRI,并行旷场试验评估功能结局。
主要发现
- MAC在出血后1天见于血肿内并持续至第7天。
- 出血后2小时,ATA组脑室内血肿体积与溶媒组相似。
- 出血后1天和3天,ATA组脑室体积显著小于溶媒组,血肿内溶血少于溶媒组。
- 出血后28天,ATA组脑室扩大显著小于溶媒组,室周铁沉积显著少于溶媒组。
- 出血后28天,ATA组大鼠较溶媒组速度显著更快、移动距离更长、休息时间更少。
关键数值与推荐
- MRI用于计算脑室体积和铁沉积。
- 第28天结局以与动物基线值的比值报告,并经对数转换标准化。
- 统计分析包括Shapiro-Wilk正态性检验,两组连续变量用t检验,三组连续变量用单因素方差分析。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The pathophysiology of posthemorrhagic hydrocephalus (PHH) is not well understood, but recent data suggest blood components play a significant role. This study aimed to understand the timing of membrane attack complex (MAC) activation after intraventricular hemorrhage (IVH) and the effect of MAC inhibition on PHH development. METHODS: This study was composed of four parts. First, 24 young adult male rats underwent stereotactic intraventricular injection of autologous blood or saline and MRI on day 1, 3, or 7 after hemorrhage. Second, 18 rats underwent intraventricular injection of saline, autologous blood with aurin tricarboxylic acid (ATA) in vehicle, or autologous blood with vehicle and underwent serial MRI studies on days 1 and 3 after hemorrhage. Third, 12 rats underwent intraventricular injections as above and MRI 2 hours after hemorrhage. Finally, 24 rats underwent the intraventricular injections as above, as well as serial MRI studies on days 1, 7, 14, and 28 after hemorrhage. The MR images were used to calculate ventricular volume and iron deposition. Open field testing was performed to assess functional outcomes. Outcomes on day 28 were reported as a ratio to the animal's baseline values and normalized via log-transformation. Statistical analysis included the Shapiro-Wilk tests for normality and t-tests and 1-way analysis of variance for 2 and 3 groups of continuous variables, respectively. RESULTS: MAC was found within the hematoma 1 day after hemorrhage and persisted until day 7. Administration of ATA resulted in similar intraventricular hematoma volumes compared to vehicle 2 hours after hemorrhage. At 1 and 3 days after hemorrhage, ATA administration resulted in significantly smaller ventricular volumes and less hemolysis within the hematoma than in the vehicle animals. Administration of ATA also resulted in significantly smaller ventriculomegaly and less iron deposition in the periventricular area than in the vehicle rats 28 days after hemorrhage. Functionally, ATA rats were significantly faster, traveled longer distances, and spent less time resting than vehicle rats at 28 days. CONCLUSIONS: MAC was activated early and persisted within the hematoma until day 7 after IVH. MAC inhibition attenuated hemolysis in the clot and ventriculomegaly acutely after IVH. One month after hemorrhage, MAC inhibition attenuated ventriculomegaly and iron accumulation and improved functional outcomes.
引用
- Holste KG, Ye F, Koduri S, et al. Attenuation of ventriculomegaly and iron overload after intraventricular hemorrhage by membrane attack complex inhibition. J Neurosurg. 2023. PMID: 37948699. doi:10.3171/2023.8.JNS23667
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。